CVS Health Corp vs Home Depot Inc — how do they compare? CVS Health Corp trades at $93.49 (market cap $122.36B), while Home Depot Inc trades at $354.05 (market cap $349.77B). The key difference: Home Depot Inc is far larger — about 2.9× CVS Health Corp's market cap, and CVS Health Corp pays the higher dividend (2.78%). Which is the better fit depends on your goals.
| CVS | HD | |
|---|---|---|
Market Cap | $122.36B | $349.77B |
Sector | Health | Consumer Cyclical |
52-Week High | $110.60 | $423.42 |
52-Week Low | $64.88 | $297.51 |
Enterprise Value | $184.71B | $411.32B |
Dividend Yield | 2.78% | 2.66% |
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $95.70, down 0.54% on the day, with a bearish technical signal and key support at $95. The company reported strong Q2 2026 earnings, beating estimates with EPS of $2.58 versus $1.87 expected, and raised its full-year guidance. Revenue growth remains robust, reaching $402.07 billion in 2025, though net income margin compressed to 1.18%. Analyst sentiment is overwhelmingly positive with a consensus price target of $115.00.
The outlook for CVS is cautiously optimistic, driven by operational improvements in its Aetna segment and raised cash flow guidance. Investment opportunities include potential upside to the consensus target, but risks involve margin pressures, regulatory changes impacting pharmacy benefits in 2027, and high debt levels. The stock's current valuation at a P/E of 25.25 may limit near-term gains if earnings growth slows.
Home Depot (HD) trades at $354.48, down 0.32% on the day, with a bullish technical signal from moving averages and a consensus analyst price target of $368.75. Recent earnings showed mixed results, with Q1 2026 beating expectations but Q3 2025 missing, while revenue grew to $159.51B in 2025. The stock faces headwinds from weak big-ticket demand and rising mortgage rates, as noted in recent news, but benefits from strong Pro segment growth and housing market tailwinds.
The outlook remains cautiously optimistic, with upside potential from analyst targets and operational resilience, though risks include margin pressure and economic sensitivity. Investors should weigh solid fundamentals against near-term volatility in housing-related spending.
Trailing returns across standard periods
Latest headlines on both assets
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →Home Depot is the world's largest home improvement specialty retailer, operating more than 2,300 warehouse-format stores offering more than 30,000 products in store and 1 million products online in the United States, Canada, and Mexico. Its stores offer numerous building materials, home improvement products, lawn and garden products, and decor products and provide various services, including home improvement installation services and tool and equipment rentals. The acquisition of distributor Interline Brands in 2015 allowed Home Depot to enter the maintenance, repair, and operations business, which has been expanded through the tie-up with HD Supply (2020). The addition of the Company Store brought textile exposure to Home Depot's lineup.
Read more on HD →